These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8287597)

  • 41. The effect of drugs on the mortality of mice inoculated with Friend leukaemia virus or toxoplasma gondii.
    Starec M; Sinet M; Kodym P; Rosina J; Fiserová A; Desforges B; Rouveix B
    Physiol Res; 1997; 46(2):107-11. PubMed ID: 9727501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoimmunity and counter-autoimmunity in the mechanisms of retrovirus-induced leukemogenesis.
    Ter-Grigorov V
    Leukemia; 1992; 6 Suppl 3():171S-173S. PubMed ID: 1318469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cuttine edge: T cells from aged mice are resistant to depletion early during virus infection.
    Jiang J; Anaraki F; Blank KJ; Murasko DM
    J Immunol; 2003 Oct; 171(7):3353-7. PubMed ID: 14500628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experimental study on blocking immune escape of leukemia cells in the recipient after bone marrow transplantation].
    Hu ZB; Zhang YS; Li AX; Liu LB; Zou P
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):402-6. PubMed ID: 14642175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Failure of mice infected with Rauscher leukemia virus (RLV-A) to develop splenic colonies.
    Bergson A; LoBue J; Fredrickson TN; Gordon AS
    J Surg Oncol; 1977; 9(2):117-21. PubMed ID: 266633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of sustained hypertransfusion on Rauscher leukemia virus-variant A (RLV-A) infection in BALB/c mice.
    Leonardi GP; Manthos M; LoBue J; Orlic D; Mitra J
    Adv Exp Med Biol; 1988; 241():191-8. PubMed ID: 3223406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia.
    Grau GE; Morrow D; Izui S; Lambert PH
    J Immunol; 1986 Jan; 136(2):686-91. PubMed ID: 3455704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition by streptovaricins of Rauscher leukemia virus splenomegaly.
    Borden EC; Carter WA; Sensenbrenner LL; Owens AH; Lichtenstein J; Gray GD; Neil GL; Nichol FR; Li LH
    Int J Cancer; 1974 Dec; 14(6):817-25. PubMed ID: 4156850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of retrovirally induced immunosuppression acting via dendritic cells.
    Knight SC
    Adv Exp Med Biol; 1995; 378():423-7. PubMed ID: 8526109
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
    Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
    Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
    Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
    J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of phenylhydrazine pretreatment on splenectomized Rauscher leukemia virus-infected mice.
    Bergson A; Lobue J; Gordon AS; Fredickson TN
    J Surg Oncol; 1978; 10(3):239-43. PubMed ID: 651372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection.
    Kraft AR; Krux F; Schimmer S; Ohlen C; Greenberg PD; Dittmer U
    Blood; 2007 Apr; 109(7):2982-4. PubMed ID: 17148590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-12 restores dendritic cell function and cell-mediated immunity in retrovirus-infected mice.
    Williams NJ; Harvey JJ; Duncan I; Booth RF; Knight SC
    Cell Immunol; 1998 Feb; 183(2):121-30. PubMed ID: 9606996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained hypertransfusion and induction of a transplantable myeloid leukemia in RLV-A-infected BALB/c mice.
    Leonardi GP; Lobue J; Manthos M; Orlic D; Mitra J
    Ann N Y Acad Sci; 1989; 554():88-115. PubMed ID: 2735654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of intestinal lesions in nu/nu mice induced by transfer of lymphocytes from syngeneic mice infected with murine retrovirus.
    Suzuki K; Narita T; Yui R; Ohtsuka K; Inada S; Kimura T; Okada Y; Makino M; Mizuochi T; Asakura H; Fujiwara M
    Gut; 1997 Aug; 41(2):221-8. PubMed ID: 9301502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.
    Levite M; Zinger H; Zisman E; Reisner Y; Mozes E
    Cell Immunol; 1995 Apr; 162(1):138-45. PubMed ID: 7704902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adoptive transfer of resistance to murine retrovirus-induced immune suppression.
    Gilmore GL
    Cell Immunol; 1996 Apr; 169(1):24-9. PubMed ID: 8612290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.